Back to results
US 2026/0263573 A1Published application
Tumor Immunotherapy
AssigneesPingShan Translational Medicine Center, Shenzhen Bay Laboratory, Peking University Shenzhen Graduate School
InventorsZigang Li, Feng Yin, Yaping Zhang, Leying Jiang, Zhaodi Liu
Life of this patent
Estimating the term…
Abstract
Disclosed is a composition comprising a closed-loop peptide comprising at least two methionines and at least two sulfonium centers; and a conjugate of a negatively charged immunoadjuvant and a peptide.
Claims28
A composition comprising:
- a closed-loop peptide comprising at least two methionines and at least two sulfonium centers;
- and
- a conjugate formed by a negatively charged immunoadjuvant and a peptide.
A nanoparticle comprising:
- a closed-loop peptide comprising at least two methionines and at least two sulfonium centers;
- and
- a conjugate formed by a negatively charged immunoadjuvant and a peptide,
- wherein the closed-loop peptide is self-assembled with the conjugate to form the nanoparticle.
1 more element
Dependencies are inferred from the claim text.